期刊文献+

晚期糖基化终末产物对骨组织生物力学影响的研究进展 被引量:3

Progress in Advanced Glycation End-Products Effects on Biomechanics of Bone Tissues
下载PDF
导出
摘要 晚期糖基化终末产物(advanced glycation end-products,AGEs)是大分子物质的游离氨基与还原糖之间发生的非酶促反应产物。AGEs在骨组织中积聚会通过与骨组织细胞表面受体的结合改变骨组织细胞活性及功能,引起骨重建过程异常。AGEs积聚还会改变骨胶原原有结构及矿物质沉积,影响骨组织的微观力学性能,造成骨强度及韧性的降低,增加骨折风险,导致骨疾病的发生,危害人体健康。概述AGEs的产生原因及检测方法,并从微观和宏观层面综述AGEs在生物体骨组织内积聚对骨生物力学影响的研究进展,为临床上对骨疾病的早期诊断与治疗提供参考。 Advanced glycation end-products(AGEs)are the products of non-enzymatic reactions between free amino groups of macromolecules and reducing sugars.AGEs accumulation in bone tissues changes the activity and function of bone cells by binding to their surface receptors,causing abnormalities in the process of bone remodeling.AGEs accumulation can also change the original structure and mineral deposition of bone collagen,affect the micro-mechanical properties of bone tissues,and further reduce bone strength and toughness,increase the bone fracture risk,which will lead to bone diseases and do great harm to human health.This article summarized the causes of AGEs and their detection methods,and reviewed previous studies about the effects of AGEs accumulation on bone biomechanics at micro and macro levels,so as to provide references for the early diagnosis and treatment of bone diseases in clinic.
作者 毛岩 杨肖 孙联文 MAO Yan;YANG Xiao;SUN Lianwen(Beijing Advanced Innovation Center for Biomedical Engineering,Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education,School of Biological Science and Medical Engineering,Beihang University,Beijing 100083,China)
出处 《医用生物力学》 CAS CSCD 北大核心 2021年第5期811-817,共7页 Journal of Medical Biomechanics
基金 国家自然科学基金项目(11802010,11827803) 中央高校基本科研业务费专项资金 中国科协第三届青年托举人才项目。
关键词 晚期糖基化终末产物 骨组织 胶原 生物力学 advanced glycation end-products(AGEs) bone tissues collagen biomechanics
  • 相关文献

参考文献2

二级参考文献23

  • 1李友元,邓洪波,王蓉,张萍,陈珑珑.糖尿病鼠肾脏组织损伤机制及二甲双胍的保护作用[J].医学临床研究,2005,22(5):641-642. 被引量:5
  • 2ZhouX,WangB,ZhuL,etal.Anovelimprovedtherapystrategyfordiabeticnephropathy:TargetingAGEs[J].Organogenesis,2012,8(1):18-21.
  • 3ViolletB,GuigasB,SanzGN,etal.Cellularandmolecularmechanismsofmetformin:anoverview[J].ClinSci(Lond),2012,122(6):253-70.
  • 4IshibashiY,MatsuiT,TakeuchiM,etal.Beneficialeffectsofmetforminandirbesartanonadvancedglycationendproducts(AGEs)RAGEinducedproximaltubularcellinjury[J].PharmacolRes,2012,65(3):297-302.
  • 5IshibashiY,MatsuiT,TakeuchiM,etal.Metformininhibitsadvancedglycationendproducts(AGEs)inducedgrowthandVEGFexpressioninMCF7breastcancercellsbysuppressingAGEsreceptorexpressionviaAMPactivatedproteinkinase[J].HormMetabRes,2013,45(5):387-90.
  • 6WuD,WenW,QiCL,etal.Ameliorativeeffectofberberineonrenaldamageinratswithdiabetesinducedbyhighfatdietandstreptozotocin[J].Phytomedicine,2012,19(8-9):712-8.
  • 7TzengTF,LiouSS,ChangCJ,etal.TheethanolextractofZingiberzerumbetattenuatesstreptozotocininduceddiabeticnephropathyinrats[J].EvidBasedComplementAlternatMed,2013,2013:340645.
  • 8PiwkowskaA,RogackaD,JankowskiM,etal.MetformininducessuppressionofNAD(P)Hoxidaseactivityinpodocytes[J].BiochemBiophysResCommun,2010,393(2):268-73.
  • 9林虹,朱鹏立.晚期糖基化终末产物及其受体在原发性高血压中的作用机制[J].国际老年医学杂志,2010,31(4):165-170. 被引量:8
  • 10乔进,窦志华,吴锋,孟国梁,陈惠,郑惠华.灵芝多糖联合二甲双胍对2型糖尿病大鼠心肌AGEs及CTGF的影响及其机制[J].中国药理学通报,2014,30(4):536-541. 被引量:13

共引文献15

同被引文献57

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部